Comprehensive answers regarding research peptides, analytical standards, ordering processes, and laboratory handling.
Research peptides are synthetic research peptides used in controlled laboratory environments for scientific and analytical study. They are short chains of amino acids designed to help researchers investigate biochemical interactions, receptor pathways, and molecular behavior.
Laboratory grade peptides are produced through controlled synthesis processes and are intended strictly for research use only. They are not approved for human or veterinary use and are supplied solely for laboratory research applications.
Peptides are used in laboratory research to study cellular signaling, receptor binding, metabolic pathways, and molecular mechanisms. In scientific settings, synthetic research peptides assist researchers in exploring biological processes under controlled experimental conditions.
Research applications vary depending on the peptide’s structure and classification, but all materials supplied by 99 Purity Peptides are designated exclusively for laboratory research use.
No. All products are supplied for research use only. They are not intended for human or veterinary use, diagnosis or treatment.
Laboratory grade peptides are specifically designated for research use only and are not intended for pharmaceutical, dietary, or therapeutic use.
The distinction lies in classification, documentation, and intended application. Research classification peptides are distributed for analytical and experimental study within laboratory environments and are labeled accordingly to prevent misuse outside of research settings.
High purity peptides refer to synthetic research peptides that meet defined analytical purity benchmarks after synthesis and purification.
Purity levels are typically verified using analytical testing methods. High purity is important in laboratory research because impurities may interfere with experimental consistency and reproducibility.
Research peptides may be legally purchased in the United States when intended strictly for laboratory research purposes. However, regulatory status can vary depending on the compound and its classification.
Buyers are responsible for understanding and complying with applicable federal, state, and local regulations before purchase. 99 Purity Peptides supplies synthetic research peptides under research-use-only designation.
“For Research Use Only” indicates that a product is intended strictly for laboratory and analytical research applications.
It means the product is not approved for human consumption, veterinary use, diagnosis, treatment, ingestion, injection, or therapeutic application. Research use only designation clarifies that materials are supplied exclusively for controlled scientific study.
Research peptides sold for laboratory use have not been evaluated or approved by the U.S. Food and Drug Administration (FDA).
They are classified as research materials and are not authorized as pharmaceutical drugs, dietary supplements, or medical treatments. FDA approval applies to drugs and medical products, not to research-use-only materials.
No. Synthetic research peptides designated for research use only are intended exclusively for controlled laboratory environments.
They are not approved for human use, veterinary use, or any application outside of scientific research settings.
Research peptides may fall under regulatory oversight depending on their classification and intended use.
Compliance responsibility ultimately rests with the purchaser to ensure materials are used in accordance with applicable regulations and research guidelines.
A Certificate of Analysis (COA) is a document that provides analytical testing results for a specific product batch.
For peptides with COA documentation, the certificate typically includes purity percentages, batch numbers, and analytical method summaries. COA documentation supports transparency and helps researchers verify peptide purity prior to use.
As a lab tested peptide supplier, 99 Purity Peptides relies on structured analytical verification processes to confirm identity and purity benchmarks.
Analytical testing peptides may be evaluated using techniques such as HPLC or mass spectrometry to ensure consistency and structural integrity prior to release.
Where applicable, third party tested peptides may undergo external analytical confirmation in addition to internal quality procedures.
Third-party testing provides an additional layer of verification for purity and identity standards.
Peptide identity is typically confirmed through analytical testing procedures that verify molecular mass and structural composition.
Techniques such as mass spectrometry help confirm that the synthesized peptide matches its intended sequence.
To verify peptide purity, researchers should review available analytical documentation such as a Certificate of Analysis (COA).
Purity verification typically involves reviewing HPLC chromatograms and purity percentage results provided for the specific batch.
When evaluating how to choose a peptide supplier, researchers should look for:
• Clear research classification
• Transparent documentation practices
• Peptides with COA availability
• Third-party testing standards
• Defined research use only positioning
A trusted peptide supplier emphasises analytical verification and compliance clarity.
Yes. 99 Purity Peptides operates as a peptide supplier USA researchers source from for laboratory-grade materials.
We ship research peptides across the United States in accordance with research-use-only designation standards.
Yes. We provide nationwide shipping across the United States for research peptide orders.
All shipments are handled in accordance with controlled handling practices to support material stability during transit.
Where applicable, orders may include batch information and documentation related to analytical testing and purity verification.
Peptides with COA documentation can be requested when available for transparency and verification purposes.
Yes. 99 Purity Peptides offers an affiliate program for partners interested in promoting research peptide products through compliant marketing channels.
Affiliate participation is subject to approval and must align with research-use-only positioning and regulatory standards.
Peptide stability and storage conditions depend on the compound’s chemical characteristics.
In general, laboratory grade peptides should be stored according to recommended temperature guidelines to preserve structural integrity. Researchers should consult storage documentation for specific handling instructions.
Temperature control supports peptide stability by reducing the risk of degradation.
Controlled storage conditions help preserve purity levels and maintain molecular structure, especially for synthetic research peptides intended for extended laboratory use.
Cold chain handling refers to temperature-managed storage and transport procedures used to maintain material stability.
In research supply, controlled handling protocols are implemented to minimize environmental exposure and support product integrity during shipment.
It depends on the concentration you want: concentration (mg/mL) = peptide mass (mg) ÷ water added (mL). A 10mg vial in 2mL gives 5mg/mL, and on a U-100 syringe 1mL always equals 100 units.
See our complete bacteriostatic water reconstitution chart for the full mL-to-units and mg/mL tables by vial size, plus a free calculator.
A synthetic research peptide acting as a dual GIP and GLP-1 receptor agonist.
No. It is supplied strictly for laboratory research purposes only.
No. It is not intended for any form of administration.
No regulatory or medical approvals are claimed.
No clinical or experimental guidance is provided.
No. The research material itself is not FDA-evaluated.
No experimental protocols or recommendations are offered.
No. Purity may vary by batch and product.
Cellular metabolism and mitochondrial signaling studies.
No. It is not a supplement or consumable product.
No outcomes or results are implied or guaranteed.
Analytical characterization may be performed.
Telomere biology, aging models and circadian rhythm studies.
No. It is a synthetic research peptide.
No medical or health claims are made.
No outcomes are implied or guaranteed.
No dosing or application instructions are given.
No FDA evaluation or approval exists.
Neuroplasticity and cerebral signaling pathways.
No. It is a synthetic research peptide.
No. No administration methods are intended.
No human use is supported or allowed.
No regulatory approval is claimed.
GABAergic modulation and stress-response pathways.
No. It is a research peptide only.
No. It is not intended for any use application.
No research guidance is offered.
No.
Sleep architecture and circadian rhythm studies.
No. It is not a consumer or therapeutic product.
No benefits or outcomes are claimed.
No. It is not FDA-approved.
No.
Thymosin β4 protein.
Actin regulation and tissue remodeling studies.
No. It is for laboratory research only.
No.
No. Purity may vary.
A synthetic pentadecapeptide.
Cytoprotection and angiogenic signaling.
No. It is not intended for treatment.
No clinical data is provided.
No.
To study combined tissue signaling pathways.
No. It is a research formulation.
No effects are guaranteed or implied.
No.
No experimental protocols are supplied.
A multi-peptide research blend.
Joint and connective tissue stress models.
Composition may be documented internally.
No.
No.
Dermal remodeling and connective tissue signaling.
No. It is a research blend only.
No outcomes are implied.
No.
No.
Oxidative stress and cellular defense research.
No. It is for research use only.
No benefits are claimed.
No.
Analytical characterization may be conducted.
They are used in laboratory studies examining incretin signaling, metabolic regulation, insulin pathways and energy balance.
GLP-1, GIP, glucagon, ERR activation, mitochondrial metabolism and NAD-related pathways.
No. All metabolic research compounds are for laboratory research only.
Yes. This category includes both peptide-based and non-peptide oral research compounds.
Academic, private and institutional researchers studying metabolic and cellular signaling systems.
They are studied for neuroplasticity, stress-response signaling, cognitive pathways and neuroimmune interactions.
GABAergic modulation, cerebral signaling, stress-response pathways and cognitive processing systems.
No. They are strictly intended for controlled laboratory research environments.
Yes. Certain formulations are examined for combined pathway interaction research.
Researchers studying neuroscience, cognition, stress physiology and neurochemical signaling.
They are examined in studies focused on sleep architecture, circadian rhythms and neuroendocrine regulation.
Delta-wave sleep patterns, circadian timing systems and sleep-related signaling pathways.
No. They are for experimental sleep-cycle research only.
They may be naturally occurring peptides or synthetic analogs used in laboratory research.
Neuroscience and chronobiology researchers work in controlled laboratory settings.
They are studied for tissue signaling, actin regulation, angiogenic pathways and cellular repair mechanisms.
Muscle, connective tissue, joints, dermal structures and vascular-related systems.
To examine coordinated signaling pathways across multiple tissue systems.
No. They are intended solely for laboratory and experimental research.
Researchers studying tissue response, cellular repair signaling and connective tissue biology.
To study oxidative stress response, redox balance and cellular protection mechanisms.
Antioxidant signaling, mitochondrial defense and intracellular stress-response systems.
No. They are research materials only and not intended for human use.
Some are endogenous molecules studied in controlled laboratory environments.
Researchers focused on cellular biology, oxidative stress and metabolic defense mechanisms.
GHK-Cu is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, naturally present in human plasma at declining concentrations with age. In research, it functions as a signal peptide associated with collagen synthesis, fibroblast activation, antioxidant signaling, and broad gene modulation. It is supplied as a lyophilized powder for in-vitro and pre-clinical study, not for human use.
GHK-Cu consists of glycine, histidine, and lysine arranged in sequence (Gly-His-Lys), with a Cu²⁺ ion coordinated by the histidine imidazole, the N-terminal amine, and additional ligand contributions. The parent complex has a molecular weight near 403–404 g/mol, and the acetate-salt form near 462 g/mol. The deep cobalt-blue color confirms copper binding.
Investigators describe GHK-Cu as a signal peptide that engages multiple cellular pathways rather than a single receptor. Reported activities include fibroblast stimulation, controlled intracellular copper delivery, modulation of collagen and glycosaminoglycan synthesis, and broad changes in gene expression across stress-response and tissue-repair networks.
Pre-clinical wound-healing models report that GHK-Cu accelerates closure and improves tensile strength through a combination of fibroblast activation, angiogenic signaling, macrophage recruitment, and matrix-protein synthesis. The copper component supports enzymes including lysyl oxidase that are critical to collagen cross-linking.
Reported pathways include TGF-β signaling, antioxidant defense (superoxide dismutase, glutathione peroxidase), extracellular-matrix gene expression (collagen types I and III, decorin, perlecan), and inflammatory cytokine modulation. The Broad Institute gene-expression dataset documents changes across 4,192 human genes following GHK exposure.
In-vitro fibroblast studies indicate that GHK-Cu upregulates transcription of collagen and elastin genes and supplies copper as a cofactor for lysyl oxidase, the enzyme that cross-links these matrix proteins. The net effect in cell culture is increased deposition of structurally mature extracellular matrix.
Common research applications include in-vitro fibroblast and keratinocyte studies, animal wound-healing models, hair-follicle and dermal-papilla research, post-procedure skin-recovery models, antioxidant-pathway investigations, and gene-expression profiling. All such work is conducted under research-use-only conditions.
Pre-clinical and cosmetic-research data describe increased collagen and elastin synthesis, fibroblast proliferation, improved barrier-protein expression, and reduced markers of oxidative stress following GHK-Cu exposure. Human evidence remains limited to small panels and cosmetic-grade applications.
Yes — GHK-Cu is one of the more frequently studied compounds in dermatological wrinkle-reduction research. Pre-clinical and small human-panel studies report improvements in wrinkle depth and skin density, attributed to upregulated collagen and elastin pathways.
Multiple in-vitro fibroblast studies and a smaller number of clinical-cosmetic studies report improvements in skin elasticity associated with GHK-Cu exposure, linked to increased elastin synthesis and improved lysyl-oxidase-dependent cross-linking. The bulk of this evidence is pre-clinical.
Reported effects on texture and firmness derive from upregulated extracellular matrix production, improved barrier protein expression, and increased fibroblast activity. These outcomes are described in cosmetic-research panels and pre-clinical models; therapeutic claims are not supported by FDA approval.
In barrier-disruption models, GHK-Cu has been reported to support recovery of stratum-corneum lipids, tight-junction proteins, and ceramide synthesis. Investigators describe these effects as part of the compound's broader regenerative signaling profile.
Dermatology-research models simulating microneedling, laser, and chemical-peel injuries have reported shorter erythema duration and accelerated barrier recovery with GHK-Cu application. These findings are pre-clinical and cosmetic-research in nature, not validated therapeutic claims.
GHK-Cu interacts with dermal papilla cells and has been examined in animal-model and ex-vivo follicle studies of androgenic alopecia. Reported outcomes include increased follicle size and prolonged anagen phase. Human evidence is limited and largely cosmetic.
In ex-vivo follicle culture and rodent models, GHK-Cu has been reported to stimulate dermal papilla proliferation, increase follicle diameter, and improve scalp vascularization. Mechanistic explanations include copper-dependent enzyme cofactor support and signaling-pathway activation.
Pre-clinical work across skin, lung, liver, and bone models has reported tissue-repair activity, attributed to fibroblast restoration, antioxidant signaling, anti-inflammatory effects, and matrix-protein synthesis. The breadth of reported activity reflects the compound's broad gene-expression effects.
Pre-clinical data points to upregulation of nerve growth factor and vascular endothelial growth factor in injury models, supporting interest in nerve regeneration and angiogenesis applications. This work remains early-stage and confined to animal and in-vitro studies.
Animal-model studies report improved tensile strength of healed wounds, reduced scar volume, and accelerated closure with GHK-Cu treatment. The mechanism is multifactorial: fibroblast activation, matrix-protein modulation, and inflammatory damping.
GHK-Cu is generally well-tolerated in published in-vitro and animal-model work at standard research concentrations. Safety in human therapeutic contexts is not established, and the compound is not FDA-approved. Standard laboratory handling and personal protective equipment apply.
Published in-vitro work commonly uses GHK-Cu in the range of 10 nM to 10 μM, with 1 μM as a frequently reported working concentration. Animal-model topical studies have used 0.05–0.2% (w/v) formulations. These figures describe research literature, not clinical guidance.
GHK-Cu is water-soluble. Common research solvents include sterile water, bacteriostatic water (0.9% benzyl alcohol), and buffered saline at neutral pH. Stock solutions of 1–10 mg/mL are typical and are then diluted into culture medium for working concentrations.
Lyophilized GHK-Cu is stored at −20 °C in sealed vials with desiccant, protected from light. Reconstituted solutions are typically kept at 2–8 °C and used within weeks, with long-term storage as frozen aliquots to minimize freeze-thaw degradation.
Lyophilized GHK-Cu at −20 °C retains stability for 24 months or longer under typical research-storage conditions. Reconstituted aqueous solutions stored at 2–8 °C are generally used within 14–28 days for sensitive applications.
Reversed-phase HPLC quantifies purity (the ≥99% threshold for research grade), and liquid-chromatography mass spectrometry (LC-MS) confirms identity by measuring molecular weight. Both analyses appear on a complete certificate of analysis.
Common impurities to check include truncated peptide sequences (Gly-His or His-Lys fragments), residual coupling reagents and protecting groups, counterion residues, free (uncomplexed) GHK, and excess copper salts. A complete COA quantifies these as part of the impurity profile.
Lab-grade GHK-Cu is supplied as lyophilized powder with verified ≥99% HPLC purity, LC-MS identity confirmation, and a full COA — designated for research use only. Cosmetic-grade copper tripeptide-1 is a formulated topical product subject to cosmetic regulation, with no comparable analytical disclosure.
Research-grade GHK-Cu is available from suppliers that publish complete certificates of analysis and operate under research-use-only labeling. Verification of HPLC and LC-MS documentation, batch-level transparency, and RUO designation are standard procurement criteria.
Research-grade suppliers providing 99% purity GHK-Cu typically share batch-level HPLC chromatograms, mass spectrometry traces, and COAs on request. Procurement teams generally evaluate suppliers on documentation depth, RUO compliance, and analytical transparency.
Look for ≥99% HPLC purity standards, full LC-MS identity confirmation, transparent certificate-of-analysis documentation, clear RUO labeling, and responsive technical support. Avoid suppliers that decline to share analytical documentation or that lack batch-level traceability.
Research-grade GHK-Cu pricing varies by vial size, purity certification depth, and supplier overhead. Procurement teams should evaluate cost per milligram against the completeness of analytical documentation rather than headline price alone.
A reputable supplier provides a complete COA with HPLC chromatogram, LC-MS identity data, batch and lot number, manufacture date, purity percentage, impurity profile, storage recommendations, and reconstitution guidance.
Yes — cell culture is one of the most common GHK-Cu research contexts. Investigators commonly use 10 nM to 10 μM concentrations in fibroblast, keratinocyte, and dermal-papilla cultures. Stock solutions are typically prepared in sterile water and diluted into culture medium.
Limitations include limited large-scale human clinical evidence, challenges in extrapolating in-vitro concentrations to in-vivo contexts, stability sensitivities (light, heat, alkaline pH), and variability in supplier purity. Most current evidence is pre-clinical.
GHK-Cu differs from other signal peptides (Matrixyl, acetyl hexapeptide-8, palmitoyl tripeptides) in its copper-coordinated mechanism and broad gene-expression effects. Comparative research on combinations is an active investigative area.
GHK-Cu is sold as research-use-only because it has not been evaluated by the FDA for human therapeutic use. Research-grade material is intended for in-vitro studies, assay development, and pre-clinical animal-model work conducted in qualified laboratory settings.
GHK-Cu and copper tripeptide-1 refer to the same Gly-His-Lys-Cu(II) molecule. The distinction is regulatory and contextual: "GHK-Cu" is used in scientific literature and research supply, while "copper tripeptide-1" is the INCI cosmetic-ingredient name.
Combination research with other signal peptides (e.g., Matrixyl, palmitoyl tripeptides) is an active area in dermatological and regenerative-research literature. Whether combinations produce additive or synergistic effects remains an open question requiring further mechanistic study.
Large-scale human clinical trials on GHK-Cu remain limited. Most published evidence sits in in-vitro studies, animal models, and small cosmetic-research panels. The compound has not progressed through standard pharmaceutical-development trials for any therapeutic indication.
Standard pre-experiment verification includes reviewing the supplier COA for HPLC purity (≥99%), LC-MS identity confirmation, and impurity profile. Some laboratories conduct in-house identity verification on receipt for sensitive applications.
Research-grade GHK-Cu is supplied in the United States by RUO-compliant suppliers operating under research-reagent designation. Procurement is straightforward for academic and private research laboratories with appropriate institutional procurement procedures.
